Cite
HARVARD Citation
Wildiers, H. et al. (2018). Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet oncology. 19 (3), pp. 323-336. [Online].